Christian Michael Glibert Reports Diluted 6.5% Stake in ENvue Medical, Inc. Following Share Issuance

2026-04-17SEC Filing SCHEDULE 13D/A (0002111050-26-000004)

Christian Michael Glibert filed a Schedule 13D/A on April 17, 2026, regarding his holdings in ENvue Medical, Inc. (ticker: NAOV). While the reporting person’s absolute share count remained unchanged at 240,000 shares of Common Stock, his beneficial ownership percentage decreased significantly from approximately 22.1% to 6.5%. This reduction is entirely attributable to dilution resulting from an increase in the Issuer's total shares outstanding, which grew from 1,088,192 to 3,700,908 shares as reported in the Issuer’s Annual Report on Form 10-K filed on April 15, 2026. Glibert maintains sole voting and dispositive power over the 240,000 shares. The filing indicates that the shares are held for investment purposes, and the reporting person may adjust his position in the future based on market conditions. No shares were acquired or disposed of in the transactions leading to this specific amendment; the filing serves primarily to report the material change in ownership percentage due to the updated denominator of outstanding shares.

Ticker mentioned:NAOVInstitution mentioned:Glibert Christian Michael
Related industry:Medical Devices